DXB 5.45% 52.0¢ dimerix limited

I think we should be close to a $1 before the two big...

  1. 1,976 Posts.
    lightbulb Created with Sketch. 434
    I think we should be close to a $1 before the two big deals...and no reason shouldn't be $1.5-$2 once we sign the two deals..

    The thing is that investors on ASX don't really understand how the entire drug approval and commercialization works..I was looking at some data for Neuron and it was surprising to see that the SP went up around 7-8X from the time Neuron got FDA approval and its commercial launch (Damn I didn't knew about Neuron until then)...post FDA approval, apart from extraordinary circumstances, the chances of a company not launching the drug is very small...

    Post the FDA approval, given the TAM, I think we should be higher, much higher than NEU from a MC perspective, but I can't put a figure...

    The other thing people need to understand that if our drug works, there will be a huge confidence boost in the Receptor-HIT technology and FSGS is just a start...
    Last edited by singhgu: Friday, 09:28
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
52.0¢
Change
-0.030(5.45%)
Mkt cap ! $285.8M
Open High Low Value Volume
54.5¢ 55.5¢ 51.5¢ $1.982M 3.739M

Buyers (Bids)

No. Vol. Price($)
8 82244 52.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.0¢ 27153 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.